US2467434A
(en)
|
1947-05-10 |
1949-04-19 |
Air Associates Inc |
Servomotor and pressure responsive valve therefor
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4361549A
(en)
|
1979-04-26 |
1982-11-30 |
Ortho Pharmaceutical Corporation |
Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
|
US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
JP2624470B2
(ja)
|
1984-10-02 |
1997-06-25 |
バイオジェン インコーポレイテッド |
ストレプトアビジン様ポリペプチドの製造
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
IN165717B
(fr)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
US4851341A
(en)
|
1986-12-19 |
1989-07-25 |
Immunex Corporation |
Immunoaffinity purification system
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
US6303121B1
(en)
|
1992-07-30 |
2001-10-16 |
Advanced Research And Technology |
Method of using human receptor protein 4-1BB
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
AU4746590A
(en)
|
1988-12-28 |
1990-08-01 |
Stefan Miltenyi |
Methods and materials for high gradient magnetic separation of biological materials
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
ATE159548T1
(de)
|
1990-11-13 |
1997-11-15 |
Immunex Corp |
Bifunktionelle wählbare fusionsgene
|
GB9215540D0
(en)
|
1992-07-22 |
1992-09-02 |
Celltech Ltd |
Protein expression system
|
DE4237113B4
(de)
|
1992-11-03 |
2006-10-12 |
"Iba Gmbh" |
Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
|
EP0804590A1
(fr)
|
1993-05-21 |
1997-11-05 |
Targeted Genetics Corporation |
Genes de fusion selectables et bifonctionnels se basant sur le gene de cytosine-deaminase (cd)
|
PT700430E
(pt)
|
1993-06-04 |
2005-07-29 |
Univ Michigan |
Processo para estimular selectivamente a proliferacao das celulas t
|
DE4417598A1
(de)
|
1994-05-19 |
1995-12-14 |
Max Planck Gesellschaft |
Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
|
CA2196085C
(fr)
|
1994-07-29 |
2002-12-10 |
Hing C. Wong |
Complexes bases sur le complexe majeur d'histocompabilite et leurs applications
|
US7074904B2
(en)
|
1994-07-29 |
2006-07-11 |
Altor Bioscience Corporation |
MHC complexes and uses thereof
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
WO1996023879A1
(fr)
|
1995-01-30 |
1996-08-08 |
Terrapin Technologies, Inc. |
Corps agglutinants - multiplicite de proteines capables de lier diverses petites molecules
|
AU708375B2
(en)
|
1995-02-09 |
1999-08-05 |
University Of Washington |
Modified-affinity streptavidin
|
WO1997011183A1
(fr)
|
1995-04-11 |
1997-03-27 |
Trustees Of Boston University |
Proteines mutantes de streptavidine
|
US5629205A
(en)
|
1995-05-19 |
1997-05-13 |
Allelix Biopharmaceuticals Inc. |
Promoters for gene expression
|
EP0840797B1
(fr)
|
1995-07-25 |
2014-09-03 |
Crucell Holland B.V. |
Procedes et moyens d'apport cible de genes
|
AR005035A1
(es)
|
1995-12-11 |
1999-04-07 |
Merck Patent Ges Mit Beschränkter Haftung |
Procedimiento para preparar proteinas recombinantes en e. coli, mediante fermentacion con gran concentracion de celulas.
|
US5869270A
(en)
|
1996-01-31 |
1999-02-09 |
Sunol Molecular Corporation |
Single chain MHC complexes and uses thereof
|
US5773224A
(en)
|
1996-02-12 |
1998-06-30 |
Grandics; Peter |
Immunoselection system for cell elution
|
DE19608753C1
(de)
|
1996-03-06 |
1997-06-26 |
Medigene Gmbh |
Transduktionssystem und seine Verwendung
|
WO1997034634A1
(fr)
|
1996-03-20 |
1997-09-25 |
Sloan-Kettering Institute For Cancer Research |
Produits de recombinaison d'anticorps diriges contre le gd2, constitues d'un fragment variable (fv) a chaine simple
|
DE19637718A1
(de)
|
1996-04-01 |
1997-10-02 |
Boehringer Mannheim Gmbh |
Rekombinante inaktive Core-Streptavidin Mutanten
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
ES2221065T3
(es)
|
1996-08-16 |
2004-12-16 |
The President And Fellows Of Harvard College |
Proteinas de fusion de clase ii del mhc, solubles, monovalentes o polivalentes, y sus usos.
|
DE19641876B4
(de)
|
1996-10-10 |
2011-09-29 |
Iba Gmbh |
Streptavidinmuteine
|
WO1998040396A1
(fr)
|
1997-03-14 |
1998-09-17 |
Trustees Of Boston University |
Streptavidine a aromes multiples
|
US6391571B1
(en)
|
1997-04-01 |
2002-05-21 |
Roche Diagnostics Gmbh |
Recombinant inactive avidin mutants
|
CA2302779C
(fr)
|
1997-09-16 |
2010-02-02 |
Oregon Health Sciences University |
Molecules de cmh recombinees utiles pour la manipulation de cellules t specifiques a un antigene
|
US6232445B1
(en)
|
1997-10-29 |
2001-05-15 |
Sunol Molecular Corporation |
Soluble MHC complexes and methods of use thereof
|
US5985658A
(en)
|
1997-11-14 |
1999-11-16 |
Health Research Incorporated |
Calmodulin-based cell separation technique
|
AU765378B2
(en)
|
1998-02-19 |
2003-09-18 |
President And Fellows Of Harvard College |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
ES2249907T3
(es)
|
1998-05-23 |
2006-04-01 |
Leiden University Medical Center |
Anticuerpos de union cd40 y peptidos ctl para el tratamiento de tumores.
|
WO2000014257A1
(fr)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Recepteurs de fusion specifiques a l'antigene prostatique specifique membranaire et ses utilisations
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
US6664042B1
(en)
|
1999-01-26 |
2003-12-16 |
Cornell Research Foundation, Inc. |
Determining viral load in double negative T cells
|
DE60043534D1
(de)
|
1999-02-04 |
2010-01-28 |
Pluristem Ltd |
VERFAHREN UND VORRICHTUNG ZUR HALTUNG UND EXPANSION VON HEMATOPOIETISCHEN STAMMZELLEN UND/ODER VORLäUFERZELLEN
|
EP1048732A1
(fr)
|
1999-04-26 |
2000-11-02 |
F. Hoffmann-La Roche Ag |
Procédé de préparation des protéine secretées sous une forme pliée naturelle
|
US6849185B1
(en)
|
1999-05-14 |
2005-02-01 |
Pall Corp |
Charged membrane
|
EP1669129A1
(fr)
|
1999-05-14 |
2006-06-14 |
Pall Corporation |
Membrane électriquement chargée
|
AU5003600A
(en)
|
1999-05-14 |
2000-12-05 |
Pall Corporation |
Charged membrane
|
WO2000075347A2
(fr)
|
1999-06-07 |
2000-12-14 |
Wolfgang Hillen |
Proteines de regulation transcriptionnelle basees sur un represseur tet
|
DE19932688B4
(de)
|
1999-07-13 |
2009-10-08 |
Scil Proteins Gmbh |
Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
|
US7172759B2
(en)
|
2000-02-01 |
2007-02-06 |
Pangenetics Bv |
Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies
|
US20030235908A1
(en)
|
2000-02-24 |
2003-12-25 |
Xcyte Therapies, Inc. |
Activation and expansion of cells
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
DE60127113T2
(de)
|
2000-04-25 |
2007-06-14 |
Otsuka Pharmaceutical Co., Ltd. |
Gd3-mimetische peptide
|
US7063845B2
(en)
|
2000-04-28 |
2006-06-20 |
Gemini Science, Inc. |
Human anti-CD40 antibodies
|
AU2001259215A1
(en)
|
2000-04-28 |
2001-11-12 |
La Jolla Institute For Allergy And Immunology |
Human anti-cd40 antibodies and methods of making and using same
|
CA2410510A1
(fr)
|
2000-06-02 |
2001-12-13 |
Memorial Sloan-Kettering Cancer Center |
Cellules presentatrices d'antigene artificiel et leurs methodes d'utilisation
|
US6638728B1
(en)
|
2000-06-16 |
2003-10-28 |
Pierce Biotechnology, Inc. |
Coated surfaces with high capacity for capturing target molecules
|
WO2002040697A2
(fr)
|
2000-11-03 |
2002-05-23 |
Genentech, Inc. |
Decalages du rythme metabolique dans des fermentations exprimant des proteines de recombinaison
|
ATE338124T1
(de)
|
2000-11-07 |
2006-09-15 |
Hope City |
Cd19-spezifische umgezielte immunzellen
|
US6979556B2
(en)
|
2000-12-14 |
2005-12-27 |
Genentech, Inc. |
Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
|
EP1227321A1
(fr)
|
2000-12-28 |
2002-07-31 |
Institut für Bioanalytik GmbH |
Purification fonctionelle de lymphocytes T antigène-spécifiques par marquage réversible aux multimères MHC
|
EP1349569B1
(fr)
|
2001-01-12 |
2007-04-18 |
Becton Dickinson and Company |
Proteines de fusion mhc auto-multimerisantes et intrinsequement fluorescentes et complexes formes de ces proteines
|
GB0102568D0
(en)
|
2001-02-01 |
2001-03-21 |
Magnetic Biosolutions Sweden A |
Method
|
DE10113776B4
(de)
|
2001-03-21 |
2012-08-09 |
"Iba Gmbh" |
Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
DK1391464T3
(da)
|
2001-04-27 |
2008-01-14 |
Kirin Pharma Kk |
Anti-CD40 monoklonalt antistof
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
NZ530852A
(en)
|
2001-08-27 |
2006-11-30 |
Genentech Inc |
Methods and compositions for recombinantly producing functional antibodies or antibody fragments in prokaryotic and eukaryotic host cells
|
EP1908769A1
(fr)
|
2001-08-27 |
2008-04-09 |
Genentech, Inc. |
Système d'expression d'anticorps et ensemble
|
WO2003029462A1
(fr)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteines de la lipocaline neutrophile humaine associee a la gelatinase et de proteines apparentees
|
US7094579B2
(en)
|
2002-02-13 |
2006-08-22 |
Xoma Technology Ltd. |
Eukaryotic signal sequences for prokaryotic expression
|
AU2003222717A1
(en)
|
2002-03-01 |
2003-09-16 |
Erdmann, Volker, A. |
Streptavidin-binding peptide
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
US7754155B2
(en)
|
2002-03-15 |
2010-07-13 |
Ross Amelia A |
Devices and methods for isolating target cells
|
US20050271653A1
(en)
|
2002-04-23 |
2005-12-08 |
Meir Strahilevitz |
Methods and devices for targeting a site in a mammal and for removing species from a mammal
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
CN100343671C
(zh)
|
2002-06-24 |
2007-10-17 |
普罗福斯股份公司 |
检测和去除内毒素的方法
|
FR2841905B1
(fr)
|
2002-07-05 |
2004-09-03 |
Centre Nat Rech Scient |
Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications
|
NZ538083A
(en)
|
2002-07-17 |
2006-08-31 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
|
GB2392158B
(en)
|
2002-08-21 |
2005-02-16 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof
|
EP2359689B1
(fr)
|
2002-09-27 |
2015-08-26 |
The General Hospital Corporation |
Dispositif microfluidique pour la séparation de cellules et usage du dispositif
|
CA2513025A1
(fr)
|
2003-01-09 |
2004-07-29 |
Macrogenics, Inc. |
Systeme vectoriel a double expression servant a exprimer des anticorps dans des cellules bacteriennes et mammiferes
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
JP2006525013A
(ja)
|
2003-05-02 |
2006-11-09 |
インセプション バイオサイエンス インコーポレイティッド |
血液幹細胞の数の増幅のための装置および方法
|
JP2006524991A
(ja)
|
2003-05-08 |
2006-11-09 |
エクサイト セラピーズ インコーポレーティッド |
抗原特異的t細胞の作製および単離の方法
|
US7943393B2
(en)
|
2003-07-14 |
2011-05-17 |
Phynexus, Inc. |
Method and device for extracting an analyte
|
JP2007501622A
(ja)
|
2003-08-13 |
2007-02-01 |
サンド・アクチエンゲゼルシヤフト |
組換えポリペプチドを精製するための方法
|
GB0319601D0
(en)
|
2003-08-20 |
2003-09-24 |
Sandoz Ag |
Production process
|
GB0321100D0
(en)
|
2003-09-09 |
2003-10-08 |
Celltech R&D Ltd |
Biological products
|
GB2408507B
(en)
|
2003-10-06 |
2005-12-14 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof for specific targeting
|
KR100570422B1
(ko)
|
2003-10-16 |
2006-04-11 |
한미약품 주식회사 |
대장균 분비서열을 이용하여 항체 단편을 분비·생산하는 발현벡터 및 이를 이용하여 항체 단편을 대량 생산하는 방법
|
JP2007512528A
(ja)
|
2003-11-20 |
2007-05-17 |
バイオセンサー、アプリケーションズ、スエーデン、アクチボラグ |
所定の抗原混合物に特異的な少なくとも2種類の異なる抗体の混合物およびその混合物の使用
|
US7985564B2
(en)
|
2003-11-21 |
2011-07-26 |
Pfenex, Inc. |
Expression systems with sec-system secretion
|
SE0400181D0
(sv)
|
2004-01-29 |
2004-01-29 |
Gyros Ab |
Segmented porous and preloaded microscale devices
|
ZA200606913B
(en)
|
2004-03-11 |
2008-03-26 |
Genentech Inc |
Process for producing polypeptides
|
US7776583B2
(en)
|
2004-06-03 |
2010-08-17 |
Meso Scale Technologies, Llc |
Methods and apparatuses for conducting assays
|
EP1800136B1
(fr)
|
2004-10-15 |
2011-12-07 |
Danisco US Inc. |
Criblage differentiel competitif
|
WO2006058226A2
(fr)
|
2004-11-24 |
2006-06-01 |
The Trustees Of Boston University |
Streptavidines dimeres modifiees et leurs utilisations
|
US20060252087A1
(en)
|
2005-01-18 |
2006-11-09 |
Biocept, Inc. |
Recovery of rare cells using a microchannel apparatus with patterned posts
|
AU2006298767B2
(en)
|
2005-09-28 |
2013-01-10 |
Cytos Biotechnology Ag |
Interleukin-1 conjugates and uses thereof
|
US7704708B2
(en)
|
2006-02-13 |
2010-04-27 |
Uti Limited Partnership |
Monomeric streptavidin muteins
|
US7855057B2
(en)
|
2006-03-23 |
2010-12-21 |
Millipore Corporation |
Protein splice variant/isoform discrimination and quantitative measurements thereof
|
WO2007117602A2
(fr)
|
2006-04-07 |
2007-10-18 |
Biogen Idec Ma Inc. |
Isolation et utilisation de lymphocytes t regulateurs humains
|
GB2442048B
(en)
|
2006-07-25 |
2009-09-30 |
Proimmune Ltd |
Biotinylated MHC complexes and their uses
|
US20080085532A1
(en)
|
2006-09-18 |
2008-04-10 |
Jorn Gorlach |
Method for determining the immune status of a subject
|
EP1905839B2
(fr)
|
2006-09-22 |
2019-07-10 |
Wacker Chemie AG |
Procédé de production de protéines fermentative
|
DE102006044841A1
(de)
|
2006-09-22 |
2008-04-03 |
Wacker Chemie Ag |
Signalpeptid zur Produktion von rekombinanten Proteinen
|
ATE501266T1
(de)
|
2006-09-22 |
2011-03-15 |
Wacker Chemie Ag |
Verfahren zur fermentativen herstellung von antikörpern
|
DK1903105T3
(da)
|
2006-09-22 |
2010-06-28 |
Wacker Chemie Ag |
Fremgangsmåde til fermentativ fremstilling af proteiner
|
EP2695895A1
(fr)
|
2006-10-17 |
2014-02-12 |
Oncotherapy Science, Inc. |
Vaccins de peptide pour cancers exprimant les polypeptides MPHOSPH1 ou DEPDC1
|
CN101568834A
(zh)
|
2006-11-02 |
2009-10-28 |
协和梅迪克斯株式会社 |
待测组分的免疫测定方法
|
AU2007353319A1
(en)
|
2006-11-15 |
2008-11-20 |
Invitrogen Dynal As |
Methods for reversibly binding a biotin compound to a support
|
CN101226118B
(zh)
|
2007-01-19 |
2010-06-16 |
中国医学科学院肿瘤研究所 |
一种兼容免疫荧光分析的细胞化学染色方法及其用途
|
BRPI0807834A2
(pt)
|
2007-01-31 |
2014-07-22 |
Dow Global Technologies Inc |
" sequências-líder bacterianas para expressão aumentada ".
|
KR20080076622A
(ko)
|
2007-02-16 |
2008-08-20 |
포항공과대학교 산학협력단 |
올리고머화된 단백질 전달체와 이를 이용한 세포내바이러스 벡터 전달 방법
|
EP2137308B1
(fr)
|
2007-03-26 |
2016-08-03 |
Agenus Inc. |
Affichage de surface d'une cellule, criblage et production de protéines d'intérêt
|
EP2155782A2
(fr)
|
2007-03-26 |
2010-02-24 |
Dako Denmark A/S |
Complexes peptidiques du cmh et leurs utilisations dans des maladies infectieuses
|
DK2537416T3
(en)
|
2007-03-30 |
2015-01-05 |
Sloan Kettering Inst Cancer |
Constitutive expression of costimulatory ligands ON adoptively transferred T-LYMPHOCYTES
|
EP2167536A1
(fr)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Procedes ameliores pour produire, marquer et utiliser des multimeres du cmh
|
EP2193199B1
(fr)
|
2007-08-20 |
2013-11-06 |
Nextera AS |
Expression à la surface des phages par l'intermédiaire de pvii
|
ES2319061B1
(es)
|
2007-09-11 |
2010-02-10 |
Biomedal, S.L. |
Metodo de conservacion de peptidos o proteinas.
|
WO2009039854A2
(fr)
|
2007-09-27 |
2009-04-02 |
Dako Denmark A/S |
Multimères cmh dans le diagnostic, le vaccin et le traitement de la tuberculose
|
JP5456689B2
(ja)
|
2007-12-07 |
2014-04-02 |
ミルテンイ バイオテック ゲーエムベーハー |
試料を少なくとも2つの成分に分離する遠心分離機
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
CA2712303C
(fr)
|
2008-01-18 |
2015-03-31 |
President And Fellows Of Harvard College |
Procedes de detection de signatures d'une maladie ou d'etats dans des fluides corporels
|
JP5562257B2
(ja)
|
2008-01-30 |
2014-07-30 |
ピーリス アーゲー |
ヒトc−met受容体のチロシンキナーゼに対し親和性を有する涙液リポカリンの変異タンパク質、及びそれを得るための方法
|
EP2254592B1
(fr)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Multimères de mhc dans le diagnostic et le traitement de la borréliose
|
US20120164718A1
(en)
|
2008-05-06 |
2012-06-28 |
Innovative Micro Technology |
Removable/disposable apparatus for MEMS particle sorting device
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
CN101446576B
(zh)
|
2008-12-29 |
2011-06-22 |
江苏省苏微微生物研究有限公司 |
一种微囊藻毒素-lr单抗免疫亲和柱的制备和使用方法
|
WO2010080032A2
(fr)
|
2009-01-09 |
2010-07-15 |
Stichting Het Nederlands Kanker Instituut |
Transduction virale assistée par des billes
|
DE102009018647A1
(de)
|
2009-04-23 |
2010-10-28 |
Osram Opto Semiconductors Gmbh |
Strahlungsemittierende Vorrichtung
|
US20110070581A1
(en)
|
2009-04-27 |
2011-03-24 |
Amit Gupta |
Separation of Leukocytes
|
US20120214187A1
(en)
|
2009-11-02 |
2012-08-23 |
Ffina Biolutions, Llc |
Method for Enhancing the Sensitivity of Antibody Based Assays
|
CA2780143A1
(fr)
|
2009-11-05 |
2011-05-12 |
Genentech, Inc. |
Procedes et composition de secretion de polypeptides heterologues
|
CA2781099A1
(fr)
|
2009-11-17 |
2011-05-26 |
Janssen Biotech, Inc. |
Secretion amelioree de proteines membranaires bacteriennes
|
US20120321665A1
(en)
|
2009-12-14 |
2012-12-20 |
Benaroya Research Institute At Virginia Mason |
Compositions and methods for treating airway inflammatory diseases
|
US9637719B2
(en)
|
2013-12-06 |
2017-05-02 |
Douglas T. Gjerde |
Devices and methods for purification of biological cells
|
US9891148B2
(en)
|
2010-02-09 |
2018-02-13 |
Douglas T. Gjerde |
Method and apparatus for pipette tip columns
|
US9242244B2
(en)
|
2010-02-09 |
2016-01-26 |
Douglas T. Gjerde |
Method and apparatus for pipette tip columns
|
US9370732B2
(en)
|
2013-02-15 |
2016-06-21 |
Douglas T. Gjerde |
Methods for purifying biological cells
|
GB201002730D0
(en)
|
2010-02-18 |
2010-04-07 |
Uni I Oslo |
Product
|
EP2363501A1
(fr)
|
2010-03-02 |
2011-09-07 |
Universitätsklinikum Hamburg-Eppendorf |
Nanocomposites dotés d'une homogénéité améliorée
|
JP5665021B2
(ja)
|
2010-03-08 |
2015-02-04 |
国立大学法人東京農工大学 |
融合mhc分子連結磁気微粒子、抗原ペプチドのスクリーニング方法、組換えベクター、及び磁性細菌の形質転換体
|
EP2585189A2
(fr)
|
2010-06-23 |
2013-05-01 |
Stobbe Tech A/s |
Appareils de traitement biopharmaceutique assemblés en une colonne
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
US9410157B2
(en)
|
2010-07-30 |
2016-08-09 |
Wisconsin Alumni Research Foundation |
Systems and methods for the secretion of recombinant proteins in gram negative bacteria
|
EP2601521B1
(fr)
|
2010-08-06 |
2018-05-02 |
Ludwig-Maximilians-Universität München |
Identification d'antigènes cibles de lymphocytes t
|
WO2012044999A2
(fr)
|
2010-10-01 |
2012-04-05 |
Ludwig Institute For Cancer Research Ltd. |
Multimères de protéines réversibles, et leurs procédés de production et d'utilisation
|
WO2012058627A2
(fr)
|
2010-10-29 |
2012-05-03 |
Miqin Zhang |
Système de nanoparticules préciblées et procédé de marquage de particules biologiques
|
DK2649086T3
(en)
|
2010-12-09 |
2017-09-18 |
Univ Pennsylvania |
USING CHEMICAL ANTIGEN RECEPTOR-MODIFIED T-CELLS TO TREAT CANCER
|
CN106074601A
(zh)
|
2011-03-23 |
2016-11-09 |
弗雷德哈钦森癌症研究中心 |
用于细胞免疫治疗的方法和组合物
|
JP5840857B2
(ja)
|
2011-04-08 |
2016-01-06 |
国立大学法人 東京大学 |
細胞傷害性t細胞誘導用組成物
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
EP3418295B1
(fr)
|
2011-07-18 |
2020-09-02 |
IBA GmbH |
Procédé de coloration réversible d'une cellule cible
|
WO2013038272A2
(fr)
|
2011-09-13 |
2013-03-21 |
Uti Limited Partnership |
Mutéine streptavidine présentant une liaison réversible pour une biotine, et protéines marquées par un peptide de liaison à la streptavidine
|
CA2855358C
(fr)
|
2011-11-11 |
2021-03-16 |
Fred Hutchinson Cancer Research Center |
Immunotherapie par des lymphocytes t ciblant la cycline a1 pour le traitement du cancer
|
US9447194B2
(en)
|
2012-02-13 |
2016-09-20 |
Seattle Children's Hospital |
Bispecific chimeric antigen receptors and encoding polynucleotides thereof
|
WO2013126726A1
(fr)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Lymphocytes t doubles transgéniques comportant un car et un tcr, et leurs procédés d'utilisation
|
EP2817625A2
(fr)
|
2012-02-23 |
2014-12-31 |
Stage Cell Therapeutics GmbH |
Isolement chromatographique des cellules et d'autres materiaux biologiques complexes
|
KR102276888B1
(ko)
|
2012-05-03 |
2021-07-14 |
프레드 헛친슨 켄서 리서치 센터 |
증강된 친화성 t 세포 수용체 및 이의 제조 방법
|
UA114108C2
(uk)
|
2012-07-10 |
2017-04-25 |
Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем |
Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
|
US9572836B2
(en)
|
2012-07-13 |
2017-02-21 |
The Trustees Of The University Of Pennsylvania |
Methods for assessing the suitability of transduced T cells for administration
|
SG10201701339RA
(en)
|
2012-08-20 |
2017-03-30 |
Seattle Children S Hospital Dba Seattle Children S Res Inst |
Method and compositions for cellular immunotherapy
|
WO2014039044A1
(fr)
|
2012-09-06 |
2014-03-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Procédés de production de populations de cellules souches t mémoires
|
EP2711418B1
(fr)
|
2012-09-25 |
2017-08-23 |
Miltenyi Biotec GmbH |
Procédé de stimulation polyclonales de lymphocyte T par nanomatrices flexibles
|
NZ746914A
(en)
|
2012-10-02 |
2020-03-27 |
Memorial Sloan Kettering Cancer Center |
Compositions and methods for immunotherapy
|
EP2920204B1
(fr)
|
2012-11-16 |
2019-09-18 |
IBA GmbH |
Mutéines de streptavidine et procédés d'utilisation associés
|
DE112012007250T5
(de)
|
2012-12-20 |
2015-10-08 |
Mitsubishi Electric Corp. |
Fahrzeuginterne Vorrichtung und Programm
|
AU2014211438B2
(en)
|
2013-01-31 |
2017-02-02 |
Glaxo Group Limited |
Method of producing a protein
|
US9920294B2
(en)
|
2013-02-15 |
2018-03-20 |
Douglas T. Gjerde |
Devices and methods for purification, detection and use of biological cells
|
US10107729B2
(en)
|
2013-02-15 |
2018-10-23 |
Douglas T. Gjerde |
Isolation, detection and use of biological cells
|
US10220332B2
(en)
|
2013-02-15 |
2019-03-05 |
Douglas T. Gjerde |
Columns for isolation, detection and use of biological cells
|
CN103305464B
(zh)
|
2013-06-05 |
2015-04-15 |
南昌大学 |
直接分离cd4+和cd8+淋巴细胞的方法
|
US9108442B2
(en)
|
2013-08-20 |
2015-08-18 |
Ricoh Company, Ltd. |
Image forming apparatus
|
SI3083671T1
(sl)
|
2013-12-20 |
2021-02-26 |
Fred Hutchinson Cancer Research Center |
Označene kimerne efektorske molekule in njihovi receptorji
|
PL3132247T3
(pl)
|
2014-04-16 |
2022-01-03 |
Juno Therapeutics Gmbh |
Sposoby, zestawy i urządzenie do namnażania populacji komórek
|
KR102447958B1
(ko)
|
2014-04-23 |
2022-09-27 |
주노 쎄러퓨티크스 인코퍼레이티드 |
입양 치료용 면역 세포 집단의 단리, 배양 및 유전자 조작 방법
|
CA2946222C
(fr)
|
2014-04-24 |
2020-12-22 |
Miltenyi Biotec Gmbh |
Procede de production automatisee de cellules t genetiquement modifiees
|
US11150239B2
(en)
|
2014-04-30 |
2021-10-19 |
Iba Lifesciences Gmbh |
Method of isolating a target cell
|
EP3172228B1
(fr)
|
2014-07-25 |
2019-02-27 |
Theravectys |
Vecteurs lentiviraux por l'expression modulable d'un recepteur d'antigène chimerique
|
WO2016166568A1
(fr)
*
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil permettant d'augmenter une population de cellules
|
AU2016341527B2
(en)
|
2015-10-22 |
2023-04-27 |
Juno Therapeutics Gmbh |
Methods, kits, agents and apparatuses for transduction
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
MA43380A
(fr)
|
2015-12-03 |
2018-10-10 |
Juno Therapeutics Inc |
Récepteurs chimériques modifiés et compositions et procédés associés
|
MX2019008538A
(es)
|
2017-01-20 |
2019-11-05 |
Juno Therapeutics Gmbh |
Conjugados de superficie celular y composiciones y métodos celulares relacionados.
|
TW201842335A
(zh)
|
2017-04-27 |
2018-12-01 |
德商朱諾醫療公司 |
寡聚粒子試劑及其使用方法
|
US20190247846A1
(en)
|
2018-02-09 |
2019-08-15 |
Chris Suh |
Method and Apparatus for Pipette Tip Columns
|
MX2021001523A
(es)
|
2018-08-09 |
2021-05-27 |
Juno Therapeutics Inc |
Procesos para generar células modificadas y composiciones de las mismas.
|
WO2020089343A1
(fr)
|
2018-10-31 |
2020-05-07 |
Juno Therapeutics Gmbh |
Procédés de sélection et de stimulation de cellules et appareil associé
|
CN117916256A
(zh)
|
2021-05-06 |
2024-04-19 |
朱诺治疗学有限公司 |
用于刺激和转导t细胞的方法
|